CVS Health is trading at $88.53, up 4.09%, with no verified new company-specific announcement clearly explaining the September 25 move.
- A report published later that day described an oversold rebound and investor buying, but identified no discrete new corporate catalyst.
- Healthcare was up 1.27%, and major indexes were higher, offering supportive sector and market context; available evidence does not establish that backdrop as the sole explanation for the larger gain.